Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

Fig. 2

Genetical discrepancies between SPLC and sMPLC patients-CT feature oriented. A In GGO lesions, the EGFR mutation rate was lower in the sMPLC group than that in the SPLC group (44.8% vs. 61.7%, p < 0.05), while BRAF mutation was more frequently observed in sMPLC cases (18.1% vs. 5.0%, p < 0.05). B Gene mutation status had no differences between the two groups in mGGO lesions. C In solid lesions, the EGFR mutation was significantly higher in the sMPLC group than in SPLC patients (79.2% vs. 41.3%, p < 0.01)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us